StonvexLoading…
StonvexCore line items from MET's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-04 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $19.70B | $734.00M | $2.44B | $1.84B | $1.22B |
Operating Income | Not available | $1.63B | $6.14B | $4.46B | $2.81B |
Net Income | Not available | $1.19B | $3.38B | $2.57B | $1.67B |
EPS (Diluted) | $2.41 | $1.74 | $4.71 | $3.54 | $2.32 |
Total Assets | Not available | $743.21B | $745.17B | $719.73B | $702.47B |
Total Liabilities | Not available | $715.41B | $716.25B | $690.53B | $674.54B |
Cash & Equivalents | Not available | $22.69B | $22.03B | $20.23B | $22.18B |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available | Not available |
Shares Outstanding | Not available | 646.02M | 655.33M | 660.72M | 666.83M |